Mc Ilrath & Eck, LLC Bristol Myers Squibb CO Transaction History

Mc Ilrath & Eck, LLC

$574 Million
Q3 2024

A detailed history of Mc Ilrath & Eck, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 1,497 shares of BMY stock, worth $86,197. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,497

Previous 1,495 0.13%

Holding current value

$86,197

Previous $62,000 24.19%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 19, 2024	BUY	$39.66 - $51.75 $79 - $103	2 Added 0.13%	1,497 $77,000
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $17,512 - $19,856	-365 Reduced 19.62%	1,495 $81,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $4,848 - $5,785	-100 Reduced 5.1%	1,860 $95,000
Q3 2023 Nov 15, 2023	SELL	$57.89 - $64.73 $1,678 - $1,877	-29 Reduced 1.46%	1,960 $113,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $8,027 - $8,913	-126 Reduced 5.96%	1,989 $127,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $68 - $81	1 Added 0.05%	2,115 $152,000
Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $3 - $1,921	25 Added 1.2%	2,114 $150,000
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $72 - $79	1 Added 0.05%	2,089 $161,000
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $922 - $1,105	15 Added 0.72%	2,088 $152,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $37,541 - $43,764	-700 Reduced 25.24%	2,073 $129,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $11,774 - $13,792	-199 Reduced 6.7%	2,773 $164,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 0.03%	2,972 $188,000
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $1,385 - $1,570	-24 Reduced 0.8%	2,971 $184,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $5,800 - $6,427	101 Added 3.49%	2,995 $181,000
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $5,372 - $6,280	-98 Reduced 3.28%	2,894 $170,000
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $11,785 - $17,127	254 Added 9.28%	2,992 $167,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $24,014 - $31,324	488 Added 21.69%	2,738 $176,000
Q3 2019 Nov 05, 2019	SELL	$42.77 - $50.71 $6,116 - $7,251	-143 Reduced 5.98%	2,250 $114,000
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $2,256 - $2,690	50 Added 2.13%	2,393 $114,000
Q4 2018 May 07, 2019	SELL	$48.76 - $63.23 $35,107 - $45,525	-720 Reduced 23.51%	2,343 $122,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $10,430 - $11,765	-189 Reduced 5.81%	3,063 $190,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $34,613 - $43,141	-685 Reduced 17.4%	3,252 $180,000
Q1 2018 May 22, 2018	SELL	$59.92 - $68.98 $65,912 - $75,878	-1,100 Reduced 21.84%	3,937 $249,000
Q4 2017 Mar 19, 2018	BUY	$59.94 - $65.35 $301,917 - $329,167	5,037	5,037 $309,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account